Use of betaxolol in the reduction of elevated intraocular pressure.
Forty eyes in 20 patients with elevated intraocular pressure were treated with either a 0.125% betaxolol ophthalmic solution or a placebo. After 2, 4, and 6 weeks of twice-daily therapy, the eyes receiving the betaxolol had a mean percent reduction in IOP greater than that in the eyes treated only with the drug vehicle (placebo). Both solutions were well tolerated.
D015784:Betaxolol; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D010919:Placebos; D011412:Propanolamines / Q000008:administration & dosage*
D010919:Placebos; D011412:Propanolamines; D015784:Betaxolol